ArticleJournal of thoracic disease2025
Impact of early acute kidney injury on 30-day mortality in intensive care unit patients with chronic obstructive pulmonary disease: a retrospective study using MIMIC-IV.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Renal Dysfunction in Chronic Obstructive Pulmonary Disease Lung-Kidney Interorgan Crosstalk with Cardiac Mediation.International journal of molecular sciences · 2026Review
- Association of the Endothelial Activation and Stress Index with Mortality in Critically Ill Patients with Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study.International journal of chronic obstructive pulmonary disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death worldwide, and acute kidney injury (AKI) is one of the most common comorbidities in patients with COPD. However, the impact of AKI occurring within 2 days of COPD diagnosis is unclear. Therefore, this study aimed to assess the impact of a 2-day onset of AKI on COPD patient outcomes using the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database. Methods: This retrospective study is based on version 2.2 of the MIMIC-IV database. We collected clinical data and 30-day all-cause mortality data for patients with COPD in the intensive care unit (ICU), who met the diagnostic criteria for COPD upon admission between 2008 and 2019. We used the International Classification of Diseases, 10th Revision (ICD-10) (codes J44, J440, J441, and J449) to identify COPD. Kaplan-Meier analysis was used to compare 30-day all-cause mortality in COPD patients with and without 2-day AKI. A Cox proportional hazards model was employed to investigate risk factors associated with 30-day all-cause mortality in COPD patients. Results: This study included 2,609 patients with COPD, of whom 1,514 (58.03%) developed AKI within 2 days, while 1,095 (41.97%) did not. Patients with COPD, those who developed AKI within 2 days were older than those who did not develop AKI within 2 days [median: 72.7 (65.1, 80.0) Conclusions: The occurrence of 2-day AKI was an independent risk factor for 30-day all-cause mortality in patients with COPD. Clinically, these findings highlight the importance of providing early kidney protection for patients with COPD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.